288154-18-7

Basic information

• Product Name: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE
• Synonyms: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE;tert-Butyl 4-amino-4-carbamoylpiperidine-1-carboxylate;1-Boc-4-aMinopiperidine-4-carboxaMide
• CAS NO: 288154-18-7
• Molecular Formula: C₁₁H₂₁N₃O₃
• Molecular Weight: 243.3
• Mol File: 288154-18-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(288154-18-7)
• EPA Substance Registry System: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(288154-18-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 288154-18-7(Hazardous Substances Data)

Usage

General Description

4-Amino-1-Boc-piperidine-4-carboxamide is a complex organic compound that belongs to the class of organic compounds known as piperidines. The 'Boc' in its name refers to tert-butyloxycarbonyl, a protective group used in organic synthesis. 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE plays a significant role in the field of medicinal chemistry due to its usage as an intermediate in the synthesis of various drugs. Some of these applications include the synthesis of pharmaceutical drugs, bioactive compounds, and research chemicals. Though specific properties such as boiling points, melting points, density or toxicity may vary depending on the purity of the sample and specific environmental factors, overall, like other piperidines, it is expected to have a basic nature due to the presence of nitrogen in the piperidine ring.

Upstream product

• 183673-71-4 4-amino-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid 
• 183673-66-7 N-Fmoc-amino-(4-N-Boc-piperidinyl)carboxylic acid 
• 331281-25-5 4-amino-4-cyano-piperidine-1-carboxylic acid tert-butyl ester 
• 288154-16-5 4-(Benzyloxycarbonylamino)-1-(tert-butoxycarbonyl)-piperidine-4-carboxylic Acid 
• 288154-17-6 1-Boc-4-[Z-amino]piperidine-4-carboxamide 

Downstream Products

• 1579514-51-4 (R)-methyl 2-(4-bromophenyl)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1579514-39-8 4-tert-butyl 4-(4-bromobenzamido)-4-carbamoylpiperidine-1-carboxylate 
• 1579514-47-8 (S)-methyl 2-(4-bromophenyl)-3-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)methyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1579514-45-6 methyl 2-(4-bromophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1579514-43-4 2-(4-bromophenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride 
• 1579514-41-2 tert-butyl 2-(4-bromophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1253925-39-1 2-(2-fluoro-4-trifluoromethyl-phenyl)-4-oxo-1,3,8-triaza-spiro[4.5]dec-1-ene-8-carboxylic acid tert-butyl ester 
• 1207203-67-5 1-{[5-(2-Chloro-4-fluorophenyl)-4-{4-[3-(tetrahydro-2H-pyran-2-yloxy)propoxy]phenyl}thien-2-yl]carbonyl}-4-[(3,3,3-trifluoropropyl)amino]piperidine-4-carboxamide 
• 1207203-33-5 tert-Butyl 4-carbamoyl-4-[(3,3,3-trifluoropropyl)-amino]piperidine-1-carboxylate 
• 865626-62-6 4-oxo-2-phenyl-1,3,8-triaza-spiro[4.5]dec-1-ene-8-carboxylic acid tert-butyl ester 
• 288154-21-2 1-(2-phenylethyl)-8-Boc-1,3,8-triazaspiro[4.5]dec-2-en-4-one 

Relevant articles and documents

Spiro compound

The invention discloses a spiro compound, application thereof and a pharmaceutical composition containing the spiro compound. The structure of the compound is shown as a formula I, and the compound has a good inhibition effect on RET kinase.

SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

ACETYL CoA CARBOXYLASE INHIBITORS

The present invention relates to acetyl coenzyme-A carboxylase (""ACC"") inhibiting compounds of the formula wherein the variables are as defined herein. In particular, the present invention relates to ACC1 and/or ACC2 inhibitors, compositions of matter,